Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 961 Print this page  Email this page Small font size Default font size Increase font size
ORIGINAL ARTICLE
Year : 2007  |  Volume : 22  |  Issue : 2  |  Page : 36-40

Myocardial perfusion scintigraphy combined with pharmacological exercise in patients with end stage renal disease on haemodialysis-diagnostic and prognostic implications


1 Nuclear Medicine, Royal Free Hospital, London, United Kingdom
2 Nuclear Medicine, Royal Free Hospital; Renal Unit, Royal Free Hospital, London, United Kingdom

Correspondence Address:
John R Buscombe
Consultant- Nuclear Medicine, Royal Free Hospital, Pond Street, London NW3 2QG
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

In patients with end stage renal disease on dialysis; cardiovascular disease is frequently under diagnosed because of the non-classical presentation of symptoms. The aim of the study was to (a) evaluate the importance and the diagnostic accuracy of 99m Tc-Tetrofosmin myocardial perfusion scintigraphy (MPS) with pharmacological exercise (b) assess the progression of coronary heart disease in patients with renal failure using a semi-quantitative method. A retrospective review was performed in 141 patients (M=86, F=55) (Mean age 56 yrs) all whom underwent stress testing with adenosine using the standard dosage regimes and were imaged with a one-day stress/rest protocol using Tc-99m tetrofosmin. 36/141 patients had an additional second stress and rest 99m Tc-myocardial perfusion scintigraphy with a mean interval of 15-months (range 12-30 months). The tomographic slices were reconstructed anduptake in the heart quantified and compared to a normal data set to remove reader bias. 95 out of 141 patients (67%) had abnormal scans, 69(73%) had reversible and 26(27%) irreversible defects. 27(28.4%) patients had perfusion abnormality involving a single territory, 35(36.8%) involving two territories, and 8(8.4%) three territories. In addition 25(26.3%) patients had diffuse or patchy perfusion abnormalities. In 36 patients who had 2 scans, there was evidence ofprogression of cardiac disease in 21/36 (58%) patients. Using objective measurement of myocardial perfusion, the vast majority of patients on dialysis have abnormal 99m Tc-Tetrofosmin myocardial perfusion scintigraphy often in more than one territory. It would also appear that there is also progression of defects seen on myocardial perfusion scintigraphy over a short time period. Myocardial perfusion scintigraphies are therefore useful in the diagnosis and follow-up of patients with renal failure on dialysis.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed573    
    Printed61    
    Emailed0    
    PDF Downloaded110    
    Comments [Add]    

Recommend this journal